Product image of Haloperidol Richter (Haloperidol) supplied by GNH India

Haloperidol Richter

Active Ingredient:
Haloperidol
Origin:
EU

Haloperidol Richter (Haloperidol)

Haloperidol Richter is a prescription oral medication that contains the active ingredient haloperidol, a butyrophenone antipsychotic. It is marketed in the European Union and is supplied without a specified strength or dosage form in the available data. The product is intended for use under medical supervision for conditions that respond to dopamine D2 receptor antagonism. It belongs to ATC code N05AD01 and is classified as a prescription‑only drug.

Manufacturer / TM Owner

Gedeon Richter Plc.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Haloperidol Richter is indicated for several psychiatric and neurological conditions where dopamine blockade is therapeutic.

  • Schizophrenia, including chronic and treatment‑resistant forms.
  • Acute psychotic episodes associated with mood disorders or substance use.
  • Mania episodes in bipolar disorder.
  • Tourette syndrome and other tic disorders.
  • Severe agitation requiring rapid control.

Side Effects

The medication may produce a range of adverse effects that are generally categorized by frequency and severity.

Common

  • Extrapyramidal symptoms such as tremor, rigidity, or akathisia.
  • Sedation or drowsiness.
  • Dry mouth and increased salivation.
  • Constipation or gastrointestinal discomfort.
  • Weight gain or appetite changes.

Serious

  • Neuroleptic malignant syndrome, a rare but life‑threatening reaction.
  • Tardive dyskinesia, characterized by involuntary movements.
  • Severe hypotension or cardiac arrhythmias.
  • Elevated prolactin levels leading to hormonal disturbances.
  • Agranulocytosis or other blood dyscrasias.

Precautions & Warnings

Clinicians should assess patient history and monitor for specific risks before and during treatment with Haloperidol Richter.

  • History of cardiovascular disease or arrhythmias.
  • Pre‑existing movement disorders or Parkinsonian symptoms.
  • Liver or renal impairment affecting drug clearance.
  • Pregnancy, lactation, or potential teratogenic risk (category unknown).
  • Concomitant use of other central nervous system depressants.
  • Elderly patients, especially those with dementia‑related psychosis.

Avoid Interactions

Haloperidol Richter can interact with other medicines, altering its effectiveness or increasing toxicity.

Avoid

  • Other dopamine antagonists or antipsychotics that may amplify extrapyramidal effects.
  • Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin) that raise haloperidol plasma levels.
  • Medications known to prolong QT interval, increasing risk of cardiac arrhythmias.

Use with caution

  • CYP3A4 inducers such as carbamazepine or rifampin, which may reduce drug exposure.
  • CNS depressants including benzodiazepines, opioids, or alcohol.
  • Anticholinergic agents that can mask extrapyramidal symptoms.
  • Antihypertensive drugs, as haloperidol may enhance hypotensive effects.

Frequently Asked Questions

Haloperidol Richter is prescribed for schizophrenia, acute psychotic episodes, manic episodes in bipolar disorder, and Tourette syndrome or other tic disorders.

The drug acts as a dopamine D2 receptor antagonist, reducing dopaminergic neurotransmission that is associated with psychotic and manic symptoms.

Common side effects include extrapyramidal symptoms (tremor, rigidity, akathisia), sedation, dry mouth, constipation, and changes in appetite or weight.

Serious reactions such as neuroleptic malignant syndrome, tardive dyskinesia, severe hypotension, cardiac arrhythmias, elevated prolactin with hormonal disturbances, and blood dyscrasias like agranulocytosis should be reported promptly.

Patients with a history of cardiovascular disease, arrhythmias, or those taking other QT‑prolonging drugs should be monitored closely because haloperidol can affect cardiac conduction.

Haloperidol can be taken with or without food; however, consistent timing relative to meals helps maintain stable blood levels.

The pregnancy safety category for Haloperidol Richter is not specified; clinicians should weigh potential benefits against risks and consider alternative therapies when possible.

Avoid concurrent use of strong CYP3A4 inhibitors, other dopamine antagonists, and medications that prolong the QT interval, as these can increase toxicity or cardiac risk.

Alcohol may enhance the sedative effects of haloperidol and increase the risk of dizziness or hypotension, so limiting alcohol intake is advisable.

Long‑term therapy may require periodic assessment of movement disorders, metabolic parameters, cardiac function (ECG), and blood counts to detect potential adverse effects early.

Patients with significant hepatic or renal dysfunction may require dose adjustments because these organs influence haloperidol clearance; clinicians should individualize therapy based on clinical judgment.

Combining haloperidol with other antipsychotics can increase the risk of extrapyramidal symptoms and should generally be avoided unless specifically directed by a specialist.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.